Загрузка...
Pre-Analytical and Clinical Validation of a Dried Blood Spot Assay for Asymmetric Dimethylarginine and L-Arginine
Asymmetric dimethylarginine (ADMA) inhibits nitric oxide (NO) synthesis. It is a risk marker for cardiovascular events and mortality in patients with cardiometabolic diseases and in population-based studies. Plasma or serum analysis of ADMA may be hampered by pre-analytical sample handling. We valid...
Сохранить в:
| Опубликовано в: : | J Clin Med |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7230730/ https://ncbi.nlm.nih.gov/pubmed/32283799 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9041072 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|